Incidence and clinical outcome of cytomegalovirus transmission via breast milk in preterm infants </=31 weeks.
about
Breast milk-acquired cytomegalovirus infection in very low birth weight infants.Prevention of maternal cytomegalovirus infection: current status and future prospects.Breast milk-acquired cytomegalovirus infection and disease in VLBW and premature infantsOverview of the diagnosis of cytomegalovirus infection.Congenital cytomegalovirus infection: new prospects for prevention and therapyAsymptomatic DNAemia heralds CMV-associated NEC: case report, review, and rationale for preemptionPredictors of severity for postnatal cytomegalovirus infection in preterm infants and implications for treatment.Incidence of CMV co-infection in HIV-positive women and their neonates in a tertiary referral centre: a cohort study.Cytomegalovirus infection in infants admitted to a neonatal intensive care unit.Incidence, Risk Factors, and Morbidity of Acquired Postnatal Cytomegalovirus Infection Among Preterm Infants Fed Maternal Milk in a Highly Seropositive Population.Guidelines for the establishment and operation of a donor human milk bank
P2860
Q33403554-333B221D-19F2-4CCA-925A-20E800578C76Q34272089-2711FE4D-EEEF-4773-B619-F03E6E67D7B0Q36850735-6E2C839B-2B7C-4F75-B1F8-B9574272246EQ37062282-2D9E034C-D259-4F0D-8A2D-F1809F9AE769Q37254183-24484EB6-B446-4912-86A8-CBB00EA7FBA0Q37268803-B5A3C5C5-B845-4213-BD08-3D45B6D75BDBQ38256190-583FDCCC-363F-4E4F-A201-3D866273F989Q41117678-1140F64F-DC8B-443A-870D-D4E0A1995ABEQ42277304-9D5772B3-F466-4B86-BA8C-6F90612F39D9Q44890444-02D67E7E-40E4-42C6-8790-D702A4191CFEQ58801459-563CECFE-E53C-496A-9E65-06F8F0DB696B
P2860
Incidence and clinical outcome of cytomegalovirus transmission via breast milk in preterm infants </=31 weeks.
description
2008 nî lūn-bûn
@nan
2008 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Incidence and clinical outcome ...... n preterm infants </=31 weeks.
@ast
Incidence and clinical outcome ...... n preterm infants </=31 weeks.
@en
type
label
Incidence and clinical outcome ...... n preterm infants </=31 weeks.
@ast
Incidence and clinical outcome ...... n preterm infants </=31 weeks.
@en
prefLabel
Incidence and clinical outcome ...... n preterm infants </=31 weeks.
@ast
Incidence and clinical outcome ...... n preterm infants </=31 weeks.
@en
P2093
P1433
P1476
Incidence and clinical outcome ...... n preterm infants </=31 weeks.
@en
P2093
Ante Miljak
Doris Fischer
Hans W Doerr
Holger F Rabenau
Horst Buxmann
Rolf L Schloesser
P304
P356
10.1111/J.1651-2227.2008.01105.X
P407
P577
2008-11-18T00:00:00Z